Insiders · Profile

Kim Christopher

Chairman and CMO at Apimeds Pharmaceuticals US. Filing since 13 May 2025. CIK 0002040022

Company

Date

Role

Action

Shares

Amount

Of holding

APUS Apimeds Pharmaceuticals US, Inc.

14 May 2025

Chairman and CMO

Bought

7,730

$14.38K

39.1%

APUS Apimeds Pharmaceuticals US, Inc.

13 May 2025

Chairman and CMO

Bought

19,770

$35.98K

opened

2 decisions on file.